Fig. 6

Validation in 35 clinical samples using multiplex immunohistochemistry. A Representative stained images of high- and low-risk groups. B Expression of NCEH1, NR1H3, TSPO, ABCA1 and HMGCR in responders and non-responders. C, D Risk scores in responders and non-responders. E Proportion of responders/non-responders in the high- and low-risk groups (using the median number for the cutoff value). F Comparison of PFS and OS (G) between high- and low-risk patients (using optimum cutoff value). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001